These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Simultaneous determination of phenytoin and phenobarbital in serum or plasma by substrate-labeled fluorescent immunoassay. Dean KJ; Thompson SG; Burd JF; Buckler RT Clin Chem; 1983 Jun; 29(6):1051-6. PubMed ID: 6303626 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of phenobarbital and phenytoin by dry-phase apoenzyme reactivation immunoassay system (ARIS). Croci D; Nespolo A; Tarenghi G Ther Drug Monit; 1987 Jun; 9(2):197-202. PubMed ID: 3303469 [TBL] [Abstract][Full Text] [Related]
17. Homogeneous substrate-labeled fluorescent immunoassay for carbamazepine. Li TM; Miller JE; Ward FE; Burd JF Epilepsia; 1982 Aug; 23(4):391-8. PubMed ID: 7047157 [TBL] [Abstract][Full Text] [Related]
18. Ligand displacement immunoassay--demonstration of its use for the measurement of serum phenobarbital and phenytoin. Hinds JA; Pincombe CF; Smith S; Duffy P Clin Chim Acta; 1985 Jul; 149(2-3):105-15. PubMed ID: 3928203 [TBL] [Abstract][Full Text] [Related]
19. Rate-nephelometric inhibition immunoassay of phenytoin and phenobarbital. Finley PR; Dye JA; Williams RJ; Lichti DA Clin Chem; 1981 Mar; 27(3):405-9. PubMed ID: 7471388 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the cloned enzyme donor immunoassay for measurement of phenytoin and phenobarbital in serum. van der Weide J; Luiting HJ; Veefkind AH Ther Drug Monit; 1993 Aug; 15(4):344-8. PubMed ID: 8236372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]